Pharmaceutical Supply – Labetalol Hydrochloride Injection

The contract involves the supply and delivery of six units of Labetalol Hydrochloride Injection, identified by NSN 6505012447982, to a Defense Logistics Agency distribution center located in Suffolk, Virginia. The product must meet all federal medical supply standards, including stringent quality, stability, and packaging requirements, and must be shipped with full traceability to ensure compliance with military and healthcare regulatory protocols. This subcontract is part of the Department of Defense’s medical procurement system, with the North American Industry Classification System code 325412 indicating pharmaceutical manufacturing as the relevant industrial category. The contract was posted on August 9, 2026, and is managed under the DLA’s contracting infrastructure, with shipment and receipt processes aligned to standardized military logistics procedures. All deliveries are subject to verification and acceptance upon arrival at the designated DLA facility, with emphasis on accurate documentation, lot tracking, and adherence to expiration and storage guidelines.